Steve Gibson
Chief Commercial Officer
Strangeworks
Steve has held a range of C-Suite positions in technology companies ranging from financial technology services, to data science consulting. Currently he serves as Chief Commercial Officer at Strangeworks; an advanced compute platform as a service (PaaS) company based in Austin, Texas. Prior to Strangeworks, Steve helped build several startups from the ground up, the most successful being Honest Dollar which was the first startup acquired by Goldman Sachs in their 147 year history. Prior to Honest Dollar, Steve worked for a number of large multinational corporations in the European aerospace sector delivering platforms for military, civil and space applications. Steve holds a Bachelor’s degree in Aerospace Systems Engineering from the University of Coventry in the UK.
Strangeworks
Website: https://strangeworks.com/
Strangeworks is on a mission to turn computational complexity into real world solutions. With the largest catalog of quantum and quantum-inspired computing resources on an innovative cloud platform backed by computational experts, we make the transformative potential of quantum computing accessible to all. Our AI powered workflows make it easier for enterprises to solve today’s toughest challenges, accelerate breakthroughs, and future-proof their operations. Partnering with customers worldwide, Strangeworks delivers immediate ROI while shaping a smarter, quantum-enabled future.
Helix AI
Website: https://helixai.com/
HelixAI is a specialist scientific technology company focused on accelerating research and development for biopharmaceutical organizations. Its platform, JarvisAI, enables scientific teams to design and execute in silico R&D workflows that support a wide range of operations from early-stage drug discovery to scale-up and bioproduction. By integrating scientific data from public, private and client domains along with computational models and AI-driven orchestration, JarvisAI helps researchers explore hypotheses more efficiently and prioritize the most promising drug candidates for further development. This approach supports better, faster decision-making combined with optimization of scientific and wet-lab resources.
Patsnap
Website: https://www.patsnap.com/
Patsnap enables IP and R&D teams to make faster, more informed decisions through advanced AI-powered intelligence. As the global leader in innovation intelligence since 2007, Patsnap provides comprehensive insights that enhance productivity and reduce inefficiencies. Patsnap's domain-specific large language model, trained on extensive proprietary innovation data, integrates with its suite of AI agents to deliver actionable intelligence that increases IP productivity by 75% and reduces R&D waste by 25%. The platform supports seamless collaboration across the complete innovation lifecycle, from patent analysis to competitive intelligence. More than 15,000 companies worldwide, including NASA, PayPal, Sanofi, Dow Chemical, and Wilson Sonsini, trust Patsnap to advance their innovation capabilities through AI.